Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiofrequency Turbinate Reduction for Persistent Allergic Rhinitis
NCT05276336Phase 3Completed
- Sponsor
- Universitas Indonesia
- Start
- Jul 2018
- Primary completion
- Feb 2020
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in allergic rhinitis (AR) (2 arms), sponsored by Universitas Indonesia. Primary endpoints: Visual Analogue Scale based on Total Nasal Symptoms Score at 8 weeks, Size of inferior turbinate at 8 weeks and 3 more. Started Jul 2018; status: completed.
02
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT05276336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05276336.